{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Carbapenems&page=2", "query": { "intervention": "Carbapenems", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Carbapenems&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T07:12:26.851Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05977868", "title": "Comparing Oral Versus Parenteral Antimicrobial Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Endovascular Infection", "Bone and Joint Infection", "Skin and Soft Tissue Infection", "Pulmonary Infection", "Gastrointestinal Infection", "Genitourinary Infection" ], "interventions": [ { "name": "Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid", "type": "DRUG" }, { "name": "Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "West Virginia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 94, "start_date": "2023-08-04", "completion_date": "2025-02-14", "has_results": true, "last_update_posted_date": "2025-08-26", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05977868" }, { "nct_id": "NCT03032380", "title": "Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthcare-associated Pneumonia (HCAP)", "Hospital Acquired Pneumonia (HAP)", "Ventilator Associated Pneumonia (VAP)" ], "interventions": [ { "name": "Cefiderocol", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2017-10-24", "completion_date": "2019-04-01", "has_results": true, "last_update_posted_date": "2020-11-13", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 15, "location_summary": "New Haven, Connecticut • DeLand, Florida • Chicago, Illinois + 12 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "DeLand", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Council Bluffs", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03032380" }, { "nct_id": "NCT01429259", "title": "Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis", "Pneumonia", "Pseudomonas Aeruginosa Infection" ], "interventions": [ { "name": "meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joseph Kuti", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 30, "start_date": "2012-02", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2018-03-20", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 7, "location_summary": "Hartford, Connecticut • Indianapolis, Indiana • New York, New York + 4 more", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01429259" }, { "nct_id": "NCT00707239", "title": "Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumonia, Bacterial" ], "interventions": [ { "name": "tigecycline", "type": "DRUG" }, { "name": "imipenem/cilastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 108, "start_date": "2008-12", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2012-07-10", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 3, "location_summary": "Louisville, Kentucky • Omaha, Nebraska • Morgantown, West Virginia", "locations": [ { "city": "Louisville", "state": "Kentucky" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00707239" }, { "nct_id": "NCT01110382", "title": "A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Abscess, Intra-Abdominal", "Abdominal Abscess", "Abdomen, Acute", "Abdominal Pain", "Appendicitis", "Rupture", "Infection", "Intestinal Perforation", "Peritonitis", "Ileus" ], "interventions": [ { "name": "Doripenem", "type": "DRUG" }, { "name": "Meropenem placebo", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Doripenem placebo", "type": "DRUG" }, { "name": "Amoxicillin/clavulanate potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 41, "start_date": "2010-12", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 4, "location_summary": "San Diego, California • Washington D.C., District of Columbia • Cleveland, Ohio + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Toledo", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01110382" }, { "nct_id": "NCT06920147", "title": "PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Surgical Site Infection" ], "interventions": [ { "name": "Ertapenem", "type": "DRUG" }, { "name": "Cefazolin and Metronidazole.", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2025-05-01", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2025-04-11", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06920147" }, { "nct_id": "NCT01570192", "title": "Clinical Trials to Reduce the Risk of Antimicrobial Resistance", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Pneumonia" ], "interventions": [ { "name": "IV meropenem", "type": "DRUG" }, { "name": "I.V. Meropenem", "type": "DRUG" }, { "name": "Parenteral aminoglycoside; tobramycin for injection USP OR gentamicin sulfate injection solution concentrate 5mg.kg IV q24h; amikacin sulfate injection USP 20 mg/kg IV q24h", "type": "DRUG" }, { "name": "Linezolid or Vancomycin (per institutional guidelines) will be available for MRSA coverage.", "type": "DRUG" }, { "name": "tobramycin nebulization", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2010-09", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2017-09-29", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 8, "location_summary": "San Mateo, California • Gainesville, Florida • Atlanta, Georgia + 5 more", "locations": [ { "city": "San Mateo", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "North Liberty", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570192" }, { "nct_id": "NCT06059846", "title": "A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Tract Infection", "Acute Pyelonephritis" ], "interventions": [ { "name": "TBP-PI-HBr", "type": "DRUG" }, { "name": "Imipenem-cilastatin", "type": "DRUG" }, { "name": "Dummy Infusion", "type": "DRUG" }, { "name": "Dummy Tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spero Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1690, "start_date": "2023-12-21", "completion_date": "2025-02-06", "has_results": true, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 2, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06059846" }, { "nct_id": "NCT01381562", "title": "GSK2251052 in the Treatment of Complicated Intra-abdominal Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infections, Intestinal" ], "interventions": [ { "name": "Drug: GSK2251052", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2011-10-03", "completion_date": "2012-03-05", "has_results": true, "last_update_posted_date": "2017-11-29", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 12, "location_summary": "Mobile, Alabama • Long Beach, California • Torrance, California + 9 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Council Bluffs", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01381562" }, { "nct_id": "NCT02168816", "title": "Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteomyelitis" ], "interventions": [ { "name": "Intravenous Antibacterial Agent", "type": "DRUG" }, { "name": "Oral Antibacterial Agent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2014-03-19", "completion_date": "2017-02-02", "has_results": true, "last_update_posted_date": "2018-07-19", "last_synced_at": "2026-09-24T07:12:26.851Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02168816" } ] }